NDC Package 68682-310-01 Metyrosine

Capsule Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68682-310-01
Package Description:
100 CAPSULE in 1 BOTTLE
Product Code:
Proprietary Name:
Metyrosine
Non-Proprietary Name:
Metyrosine
Substance Name:
Metyrosine
Usage Information:
This medication is used to treat high blood pressure in people with a certain adrenal gland tumor (pheochromocytoma). Metyrosine is used to prevent high blood pressure before and immediately after surgery to remove the tumor. It is also used long-term in people who cannot have the surgery. It is not used for other kinds of high blood pressure. Metyrosine prevents the tumor from making certain natural substances (catecholamines) that raise the blood pressure and make the heart beat faster. Lowering the amount of catecholamines lessens the risk of a very serious attack of high blood pressure (hypertensive crisis).
11-Digit NDC Billing Format:
68682031001
NDC to RxNorm Crosswalk:
  • RxCUI: 197980 - metyroSINE 250 MG Oral Capsule
  • RxCUI: 197980 - metyrosine 250 MG Oral Capsule
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Oceanside Pharmaceuticals
    Dosage Form:
    Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA017871
    Marketing Category:
    NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
    Start Marketing Date:
    09-07-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 68682-310-01?

    The NDC Packaged Code 68682-310-01 is assigned to a package of 100 capsule in 1 bottle of Metyrosine, a human prescription drug labeled by Oceanside Pharmaceuticals. The product's dosage form is capsule and is administered via oral form.

    Is NDC 68682-310 included in the NDC Directory?

    Yes, Metyrosine with product code 68682-310 is active and included in the NDC Directory. The product was first marketed by Oceanside Pharmaceuticals on September 07, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 68682-310-01?

    The 11-digit format is 68682031001. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-268682-310-015-4-268682-0310-01